Funding for this research was provided by:
Medical University of Lublin (DS.192/2019)
Received: 8 May 2019
Accepted: 16 August 2019
First Online: 31 August 2019
Ethics approval and consent to participate
: The study will be conducted in accordance with the ethical principles that have their origin in the ICH Good Clinical Practice Guidelines [CitationRef removed] and the Declaration of Helsinki [CitationRef removed]. The protocol was approved by the Ethics Committee of the Medical University of Lublin (the project identification code: KE-0254/104/2018).Patients will be informed in detail on the course of the study, all study procedures, potential risks, and the benefits of each intervention. The study outline will be given to participants in writing. The information form will contain the aim and justification for the research, statements on voluntary participation, the timeline of the study, potential risks, the manner in which the personal information will be kept confidential, and the right to withdraw from the study at any time] and without giving any reason.
: Not applicable.
: I.Ł. is a foundation shareholder in Sanprobi, a probiotics distributor. K.S-Ż and H.K-J received remuneration from Sanprobi. However, the content of this study was not constrained by this fact. Moreover, our adherence to Nutrition Journal policies on sharing of data and materials was unaffected. The other authors declare that they have no competing interests.